Tag: generic drugs
Future Role of Authorized Generics: Market Outlook
Authorized generics let brand drugmakers sell their own drugs under generic labels after patent expiry. With new FDA rules and rising biosimilar competition, their role is shifting from market control to managed transition-impacting prices, access, and competition.
Nitrosamine Contamination in Generic Drugs: Recent Recalls and Regulatory Shifts
Nitrosamine contamination in generic drugs has triggered over 500 FDA recalls since 2018. Learn which medications were affected, how regulators responded, and what it means for your health and access to affordable medicine.
Workers' Compensation and Generic Substitution: What You Need to Know in 2026
Generic substitution in workers' compensation saves billions without sacrificing care. Learn how FDA-approved generics replaced brand-name drugs in 2026, state laws, provider challenges, and why this isn't just about cost-it's about smart medicine.
Quality concerns: when clinicians question generic manufacturing
Clinicians are raising alarms about the quality of generic drugs made overseas, citing higher rates of adverse events and supply chain risks. Here’s what’s really happening behind the label.
